<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05120063</url>
  </required_header>
  <id_info>
    <org_study_id>KEK Nr. 2012-0064</org_study_id>
    <nct_id>NCT05120063</nct_id>
  </id_info>
  <brief_title>Benefit of 3-D Planning in Total Hip Replacement. A Prospective Randomized Study</brief_title>
  <official_title>Benefit of 3-D Planning in Total Hip Replacement. A Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balgrist University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Symbios Orthopedie SA</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Balgrist University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective randomized four-armed study the investigators aim to compare wheter 3-D&#xD;
      planning, which necessitates preoperative CT acquisition and sophisticated planning together&#xD;
      with engineers, results in measurable benefits in terms of objective and subjective outcome&#xD;
      values in a collective of patients undergoing primary total hip replacement.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
        1. When compared to 2-D planning, 3-D planning of a THR results in better hip&#xD;
           reconstruction, better subjective and clinical outcome and better longevity of total hip&#xD;
           implants.&#xD;
&#xD;
        2. When compared to a non-anatomical stem, an anatomical stem allows better hip&#xD;
           reconstruction, better subjective and clinical outcome and better longevity of total hip&#xD;
           implants.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients sent to our outpatient clinic for eventual primary THR are informed about this study&#xD;
      and written patient information given to them. When patients decide to undergo primary total&#xD;
      hip replacement, patient's questions with respect to this study are discussed in the&#xD;
      outpatient clinic and patients willing to participate included.&#xD;
&#xD;
      Block randomization using closed envelopes for age categories 40-50, 50-60, 60-70 years will&#xD;
      be conducted to assign the participant to one of the four study arms.&#xD;
&#xD;
      Patients will be blinded for the type of stem and method of planning. Investigators are&#xD;
      blined in terms of methods of planning. In terms of stem design, investigators can not be&#xD;
      blinded since their visibility on x-ray does not allow it.&#xD;
&#xD;
      The preoperative investigation includes routine investigation and an additional CT scan plus&#xD;
      evaluation of the &quot;University of California at Los Angeles&quot; (UCLA) activity level and &quot;Short&#xD;
      Form Health 36&quot; (SF-36) score. The same applies for the postoperative investigation and 3&#xD;
      months. The follow-up visits at 1, 5 and 10 years are routine investigations with additional&#xD;
      UCLA and SF-36 Scores.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2012</start_date>
  <completion_date type="Anticipated">January 28, 2030</completion_date>
  <primary_completion_date type="Anticipated">January 28, 2030</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)</measure>
    <time_frame>Change from basline to one year</time_frame>
    <description>The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of patients, including pain, stiffness, and physical functioning of the hip.&#xD;
A difference in WOMAC of 2.5 points is considered relevant. 3-D-planing and/or anatomical stems will be considered superior to 2-D-planing and /or non-anatomical stems if the one year WOMAC significantly differs by 2.5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in subjective hip value (SHV)</measure>
    <time_frame>Change from basline to one year</time_frame>
    <description>The subjective hip value (SHV) is as a patient-reported outcome measurement (PROM) which is reported by the patient. It is easily and quickly performed and interpreted. The SHV is defined as a patient's subjective hip satisfaction expressed as a percentage of 100%, which is the score that an entirely normal hip joint would reach.&#xD;
A difference in subj. hip value of 25% is considered relevant. 3-D-planing and/or anatomical stems will be considered superior to 2-D-planing and /or non-anatomical stems if the one year subjective hip value significantly differs by 25%.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">133</enrollment>
  <condition>Hip Injuries</condition>
  <condition>Surgery</condition>
  <condition>Prosthesis User</condition>
  <arm_group>
    <arm_group_label>3D anatomical stem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3-D-Planing with anatomical stem (SPS monoblock stem, Symbios)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3D non-anatomical stem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3-D-Planing with non anatomical stem (Quadra-H, Medacta)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2D anatomical stem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2-D-Planing with anatomical stem (SPS monoblock stem, Symbios)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2D non anatomical stem</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2-D-Planning with non anatomical Stem (Quadra-H, Medacta)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SPS monoblock stem, Symbios</intervention_name>
    <description>hip prosthesis</description>
    <arm_group_label>2D anatomical stem</arm_group_label>
    <arm_group_label>3D anatomical stem</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Quadra-H, Medacta</intervention_name>
    <description>hip prosthesis</description>
    <arm_group_label>2D non anatomical stem</arm_group_label>
    <arm_group_label>3D non-anatomical stem</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>3D planning of THR</intervention_name>
    <description>primary total-hip replacement (THR) planned on 3-dimensional images (computer tomography)</description>
    <arm_group_label>3D anatomical stem</arm_group_label>
    <arm_group_label>3D non-anatomical stem</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>2D planning of THR</intervention_name>
    <description>primary total-hip replacement (THR) planned on 2-dimensional images (anteroposteiros pelciv x-ray)</description>
    <arm_group_label>2D anatomical stem</arm_group_label>
    <arm_group_label>2D non anatomical stem</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients aged 40-70 years scheduled for primary THR&#xD;
&#xD;
          -  signed written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Charnley class B and C&#xD;
&#xD;
          -  ASA score &gt;2&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  gross hip deformity making complex hip reconstruction (greater trochanter advancement,&#xD;
             acetabular augmentation, femoral osteotomy, use of cemented or revision stem)&#xD;
             necessary&#xD;
&#xD;
          -  immature patients and patients incompetent to judge&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 6, 2021</study_first_submitted>
  <study_first_submitted_qc>November 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2021</study_first_posted>
  <last_update_submitted>November 7, 2021</last_update_submitted>
  <last_update_submitted_qc>November 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hip Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

